Satellos Bioscience (MSLE) Return on Assets (2026)
Satellos Bioscience (MSLE) posted quarterly Return on Assets of 0.0% for Q1 2026.
Satellos Bioscience (MSLE) Return on Assets (2026) Analysis & Trends
Satellos Bioscience (MSLE) has reported Return on Assets for 1 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets changed N/A year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets was little changed at 0.0% in Q1 2026 per MSLE's latest filing.
- Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Satellos Bioscience | 208.31 Mn | 208.31 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |